Clinical and biological relevance of PML breakpoints in acute promyelocytic leukemia.

被引：0
|
作者：
Khoury, H
Nevill, TJ
Dalal, BI
Shepherd, JD
Hogge, DE
Toze, CL
Conneally, EA
Sutherland, HJ
Nantel, SH
Barnett, MJ
Le, A
Brockington, DA
Vickars, LM
Horsman, DE
机构：
[1] British Columbia Canc Agcy, Leukemia BMT Program, Div Hematol, Vancouver Gen Hosp, Vancouver, BC V5Z 4E6, Canada
[2] Vancouver Gen Hosp, Vancouver, BC, Canada
[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
454
引用
下载
收藏
页码：108A / 108A
页数：1
相关论文
共 50 条
  • [31] PML-RARα fusion gene transcripts and biological features in acute promyelocytic leukemia patients
    Melo, RAM
    De Vasconcellos, JF
    Melo, FCBC
    Machado, CGF
    Lacerda, TMS
    Souto, FR
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (02): : 126 - 129
  • [32] Fulminant acute promyelocytic leukemia: Clinical and biological features.
    Di Bona, Eros
    Ferrara, Felicetto
    Specchia, Giorgina
    Leoni, Franco
    Melillo, Lorella
    Falanga, Anna
    Rossi, Giuseppe
    Fazi, Paola
    Lo Coco, Francesco
    Mandelli, Franco
    BLOOD, 2006, 108 (11) : 226B - 226B
  • [33] Obesity in newly diagnosed childhood acute promyelocytic leukemia.
    Feusner, James
    Kim, Haesook
    Gregory, John
    Alonzo, Todd
    Woods, William
    Weinstein, Howard
    Tallman, Martin
    BLOOD, 2006, 108 (11) : 202B - 202B
  • [34] Altered HOX gene expression in acute promyelocytic leukemia.
    Thompson, A
    Quinn, MF
    Grimwade, D
    O'Neill, CM
    McMullin, MF
    Cotter, FE
    Lappin, TRJ
    BLOOD, 2002, 100 (11) : 734A - 734A
  • [35] Monitoring of minimal residual disease in acute promyelocytic leukemia.
    Fleishman, EV
    Kosorukova, IS
    Baturina, YA
    Sokova, OI
    Konstantinova, LN
    Kirichenko, OP
    Popa, AV
    Baranova, OY
    Samochatova, EV
    Novichkova, GA
    Baidildina, DD
    Shamansky, SV
    Maschan, AA
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2004, 49 (05): : 3 - 8
  • [36] Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Hunt, Daniel P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1866 - 1866
  • [37] Change of hemostasis in the ATRA therapy of acute promyelocytic leukemia.
    Medvedeva, NA
    Cherepanova, VV
    Tarasova, LN
    Kudryavtseva, AV
    Kostin, AI
    Kolupaeva, OR
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2000, 45 (02): : 44 - 48
  • [38] Role of RARα-PLZF in the pathogenesis of acute promyelocytic leukemia.
    He, LZ
    Ivins, S
    Zelent, A
    Pandolfi, PP
    BLOOD, 1998, 92 (10) : 480A - 480A
  • [39] Advances in precision epigenetic treatment for acute promyelocytic leukemia.
    Pallavi, Rani
    Mazzarella, Luca
    Pelicci, Pier Giuseppe
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 163 - 178
  • [40] Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau, MM
    Davis, EM
    Patel, B
    Phan, VT
    Sohal, J
    Kogan, S
    BLOOD, 2002, 100 (11) : 136A - 136A
12345